Suppr超能文献

具有截短的C末端或第8位碱性氨基酸较短氨基酸侧链的强效催产素拮抗剂类似物。

Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.

作者信息

Flouret George, Chaloin Olivier, Slaninová Jirina

机构信息

Department of Physiology, Northwestern University Medical School, Chicago, Illinois 60611-3008, USA.

出版信息

J Pept Sci. 2003 Jun;9(6):393-401. doi: 10.1002/psc.471.

Abstract

Twelve analogues were synthesized, their structure derived from modifications of [(S)Pmp1, D-Trp2, Pen6, Arg8]oxytocin, PA, in which (S)Pmp = beta,beta-(3-thiapentamethylene-beta-mercaptopropionic acid). PA is a potent antagonist of the uterotonic effect of oxytocin in the rat (uterotonic test in vitro, pA2 = 8.86) and in the baboon. Truncated analogues of PA from the C-terminus were systematically prepared ending in either the free acid or the amide, i.e. PA1-9 acid, PA1-8 acid, PA1-7 acid, PA1-6 acid, PA1-8 amide, PA1-7 amide and PA1-6 amide. PA1-8 amide was roughly as potent as PA in the rat uterotonic assay in vitro, and the shorter amides were only somewhat weaker antagonists. All four acid analogues were weaker antagonists than PA but still maintained rather high antagonistic potency. These findings suggest that, if these truncated acids form as metabolites in vivo, they may contribute to the overall biological effect of PA and their contribution should be taken into account. Furthermore, using these analogues, the radioimmunoassay measurements of PA may be standardized, as they may cross react with PA antibodies and interfere with the determination. In addition, five analogues were made by substituting Arg8 of PA with Lys, Orn8, Dab8, Dap8 and Cit8. All of these analogues maintained high potency as OTAs in the uterotonic assay, although their activity was only about 1.5-3 times lower than PA. The most potent analogue in the uterotonic assay, [Dap8]PA, pA2 = 8.53, had weak pressor activity (pA2 = 6.90) and no antidiuretic effect. The pressor activity was lower for all tested acids, and for PA1-6 acid it was even below the detection limit. Additionally, PA1-9 acid, PA1-7 acid and PA1-6 acid showed no antidiuretic activity. Hence, the PA1-6 acid is a potent OTA with pA2 = 8.27 and no measurable effect in the pressor or antidiuretic tests and thus it is a pure oxytocin antagonist. This fact makes it an attractive candidate for further studies on inhibition of OT biological effects and on preterm labour.

摘要

合成了12种类似物,它们的结构源自[(S)Pmp1, D-Trp2, Pen6, Arg8]缩宫素(PA)的修饰,其中(S)Pmp = β,β-(3-硫杂亚戊基-β-巯基丙酸)。PA是大鼠(体外子宫收缩试验,pA2 = 8.86)和狒狒中缩宫素子宫收缩作用的强效拮抗剂。从C端系统制备了PA的截短类似物,其末端为游离酸或酰胺,即PA1-9酸、PA1-8酸、PA1-7酸、PA1-6酸、PA1-8酰胺、PA1-7酰胺和PA1-6酰胺。在大鼠体外子宫收缩试验中,PA1-8酰胺的效力与PA大致相当,较短的酰胺只是稍弱的拮抗剂。所有四种酸类似物都是比PA弱的拮抗剂,但仍保持相当高的拮抗效力。这些发现表明,如果这些截短的酸在体内作为代谢产物形成,它们可能对PA的整体生物学效应有贡献,应考虑它们的作用。此外,使用这些类似物,可以对PA的放射免疫分析测量进行标准化,因为它们可能与PA抗体发生交叉反应并干扰测定。此外,通过用Lys、Orn8、Dab8、Dap8和Cit8取代PA的Arg8制备了五种类似物。在子宫收缩试验中,所有这些类似物作为缩宫素拮抗剂都保持高效力,尽管它们的活性仅比PA低约1.5 - 3倍。子宫收缩试验中最有效的类似物[Dap8]PA,pA2 = 8.53,具有较弱的升压活性(pA2 = 6.90)且无抗利尿作用。所有测试的酸的升压活性都较低,对于PA1-6酸,其甚至低于检测限。此外,PA1-9酸、PA1-7酸和PA1-6酸没有抗利尿活性。因此,PA1-6酸是一种强效的缩宫素拮抗剂,pA2 = 8.27,在升压或抗利尿试验中无明显作用,因此它是一种纯缩宫素拮抗剂。这一事实使其成为进一步研究抑制缩宫素生物学效应和早产的有吸引力的候选物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验